FARAMERO-1000
Meropenem 1000mg Injection
Broad-spectrum carbapenem for severe and life-threatening hospital infections. WHO-GMP manufactured by Biofril Healthcare.

Product Specifications
| Brand Name | FARAMERO-1000 |
|---|---|
| Generic / Composition | Meropenem (as trihydrate) IP equivalent to Meropenem 1000mg |
| Therapeutic Category | Carbapenem Antibiotic |
| Dosage Form | Lyophilized powder for injection |
| Strength | 1000mg |
| Route of Administration | Intravenous (IV bolus or infusion) |
| Pack Size | 1 Vial with WFI |
| Storage | Store below 25°C. Protect from light. Reconstituted solution: use immediately. |
| Manufacturer | Biofril Healthcare Pvt. Ltd. · WHO-GMP Plant, Nalagarh HP |
| Prescription Status | Rx — To be sold by retail on the prescription of a Registered Medical Practitioner |
Indications & Clinical Applications
FARAMERO-1000 is indicated for the treatment of severe infections caused by susceptible gram-positive and gram-negative bacteria, particularly in critically ill hospitalized patients.
- Severe pneumonia, including hospital-acquired and ventilator-associated pneumonia
- Complicated urinary tract infections
- Complicated intra-abdominal infections
- Bacterial meningitis (adults and pediatrics)
- Septicaemia
- Febrile neutropenia in cancer patients
- Skin and soft tissue infections
- Gynaecological infections
Product Features
- WHO-GMP manufactured with full batch traceability
- Lyophilized for extended stability and longer shelf life
- Compatible with standard IV fluids
- COA issued with every batch
- Ideal for ICU and hospital tender supply
- Available for PCD franchise distribution
Warnings & Precautions
Use with caution in patients with known hypersensitivity to beta-lactam antibiotics. Adjust dose in renal impairment. Monitor for Clostridium difficile-associated diarrhoea. Pregnancy Category B — use only if clearly needed. Avoid in patients with history of severe allergic reactions to carbapenems.
This information is intended for healthcare professionals only. Always consult the complete product insert and a registered medical practitioner before prescribing or using. Biofril Healthcare is committed to pharmacovigilance — please report any adverse events to biofrilhealthcare@gmail.com.
Enquire About FARAMERO-1000
PCD franchise · Hospital tenders · Bulk supply · Distribution opportunities
Get Quote & Net Rate Call +91 97658 93730 WhatsApp
← Back to Critical Care Range | Critical Care PCD Franchise →